Project Grant K23AG093167
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded $164,117 to the University of California, San Francisco through the Aging Research program (CFDA 93.866) on August 1, 2025, to support a K23 Career Development Award for Dr. Charles Windon. This award funds Dr. Windon's training and professional development as an independent clinical researcher in biomarker-informed inequities research within Alzheimer's Disease and Related Dementias (AD/ADRD). The project deliverables...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded a $210,168 Project Grant to the Medical University of South Carolina, effective September 1, 2025, through May 31, 2030, under the Aging Research program (CFDA 93.866). This K23 career development award supports Dr. Stephanie Aghamoosa, a clinical neuropsychologist, in launching an independent research program focused on non-pharmacological interventions for secondary dementia prevention. The award funds advanced training,...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded The Johns Hopkins University a mentored patient-oriented research career development award (K01) totaling $129,659, with an award date of June 15, 2025 and completion date of March 31, 2030, under the Aging Research program (CFDA 93.866). This award funds a longitudinal research initiative examining cognitive resilience in aging and Alzheimer's disease-related dementias (ADRDs) through investigation of modifiable...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded the University of Pennsylvania $148,050 under the Aging Research program (CFDA 93.866) on October 29, 2025, for an Individual National Research Service Award (NRSA) with a completion date of May 31, 2027. This award provides research training and mentorship to enable the applicant, an experienced acute care nurse and clinical nurse specialist, to develop competencies as an independent researcher focused on...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded a K23 Career Development Award totaling $199,830 to The Regents of the University of California, San Francisco on September 10, 2025, under the Aging Research program (CFDA 93.866). This award supports Dr. Rowan Saloner's research training and development as a clinical investigator focused on identifying molecular biomarkers of frontotemporal lobar degeneration (FTLD) and other age-related dementias (ADRD). The project,...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded a Project Grant of $142,607.00 to the University of North Carolina at Chapel Hill, effective September 1, 2025, through May 31, 2030, under the Aging Research program (CFDA 93.866). Dr. Tengfei Li will develop advanced statistical and machine learning methodologies to analyze multi-center, multi-modal neuroimaging datasets for the early detection and prognosis of Alzheimer's disease (AD) and Alzheimer's disease-related...
- Grant Award Summary The University of Pennsylvania received a $214,223 Project Grant award from the National Institute on Aging under the Aging Research program (CFDA 93.866), effective March 5, 2026 through February 28, 2031. This K24 mentorship award supports the development of a comprehensive mentorship program designed to train the next generation of research leaders focused on improving clinical care delivery for older adults. Primary deliverables include recruitment and mentorship of...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded the University of Pennsylvania a $612,005 Project Grant on September 15, 2025, under the Aging Research program (CFDA 93.866) to conduct a five-year research initiative examining sleep slow-wave activity (SWA) as a potential risk factor for Alzheimer's disease in Black older adults. The research will deliver comprehensive scientific investigation and analysis services, including polysomnographic sleep monitoring,...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded a K08 Career Development Award of $163,080 to The University of Texas Health Science Center at San Antonio on September 9, 2025, under the Aging Research program (CFDA 93.866). This project, "Bridging Gaps to Translate Plasma Alzheimer's Disease Biomarkers to Diverse Populations," will deliver research services focused on advancing the clinical and research use of plasma biomarkers for Alzheimer's disease...
- Federal Grant Award Summary The University of Pennsylvania received a $6.72 million Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), awarded September 15, 2025, with a completion date of August 31, 2029. This research initiative focuses on developing short RNA therapeutics designed to combat TDP-43 proteinopathy, a pathological hallmark affecting multiple neurodegenerative disorders including amyotrophic lateral sclerosis (ALS),...
Dr. Christopher Brown at the University of Pennsylvania received a $196,020 K23 Career Development Award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), effective March 1, 2026 through February 28, 2031. This award supports Dr. Brown's research training and career development as a cognitive neurologist to advance his long-term goal of establishing an independent research career focused on understanding neuropathology propagation and clearance in Alzheimer's disease and related dementias (ADRD) using multimodal biomarkers. The primary deliverables under this award include Dr. Brown's acquisition of specialized research skills and expertise in three key areas: clinical research methods and project management in observational longitudinal studies for ADRD, longitudinal analysis of advanced magnetic resonance imaging (MRI), and biomarkers of neuroinflammation. Dr. Brown will complete both didactic training and one-on-one mentorship under the guidance of his primary mentor Dr. David Wolk and co-mentor Dr. Corey McMillan while conducting original research examining neurodegeneration and neuroinflammation in patients undergoing FDA-approved anti-amyloid therapy. The research project aims to evaluate barriers to anti-amyloid treatment effectiveness, specifically accelerated brain volume loss and amyloid-related imaging abnormalities (ARIA), through longitudinal advanced MRI and biomarker analysis of participants followed during their first year of treatment.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $196.0k | 3/2/26 |